Page 168 - Profile's Stock Exchange Handbook - 2026 Issue 3
P. 168

JSE - REM                               Profile’s Stock Exchange Handbook: 2026 - Issue 3
                                                  RATIOS
                     Remgro Ltd.                  Ret on SH Fnd  8.57  2.57  1.99  8.88  12.93
                                                  Ret On Tot Ass  8.85  4.37  4.82  4.85  9.51
                                                  Oper Pft Mgn   7.55  6.17  5.32  4.85  4.91
                                                  D:E            0.09  0.09  0.10  0.15  0.21
                                                  Current Ratio  3.51  3.74  2.07  1.86  2.31
                                                  Div Cover      5.38  1.09  0.85  7.12  15.52
                                                              NUMBER OF EMPLOYEES: 173
                                                              DIRECTORS: Lubbe M, Malherbe J (ne),
        ISIN: ZAE000026480   SHORT: REMGRO   CODE: REM         Moleketi P J (ind ne), Morobe M M (ind ne),
        REG NO: 1968/006415/06   FOUNDED: 2000   LISTED: 2000  Neethling P J (alt), Nieuwoudt G G (ne),
                                                               Ramon C (ind ne), Rantloane L (ind ne),
        NATURE OF BUSINESS:                                     Rupert A (ne), Vosloo C P (alt), Rupert J P
        Originally established in the 1940s by the late Dr Anton   (Chair, ne), de Bruyn S E N (Dep Chair, ld ind ne),
                                                               Durand J J (CEO), Williams N (CFO)
        Rupert,  Remgro’s  investment  portfolio  has  evolved   POSTAL ADDRESS: PO Box 456, Stellenbosch, 7599
        substantially since then and currently includes investee   Scan the QR code to   EMAIL: dh@remgro.com
        companies across eight pillars. The Company is listed on   visit our website  WEBSITE: www.remgro.com
        the Johannesburg Stock Exchange (JSE), operated by the   TELEPHONE: 021-888-3000
        JSE Ltd. in South Africa under the “Financials – Financial   COMPANY SECRETARY: Luche Joubert
        Services  –  Investment  Banking  and  Brokerage  Services   TRANSFER SECRETARY: Computershare Investor Services (Pty) Ltd.
                                                  SPONSOR: Rand Merchant Bank (A division of FirstRand Bank Ltd.)
        –  Diversified  Financial  Services”  sector,  with  the  share   AUDITORS: Ernst & Young Inc.
        code “REM”. From 3 January 2022, the Company also has   BANKERS: First National Bank
        a secondary listing on the A2X. Remgro’s interests consist   CALENDAR  Expected  Status
        mainly  of  investments  in  the  healthcare,  consumer   Next Final Results  Sep 2026  Unconfirmed
        products, financial services, infrastructure, industrial and   Annual General Meeting  Nov 2026  Unconfirmed
        media industries.                         Next Interim Results    Mar 2027  Unconfirmed
        Remgro’s  most  significant  investments  are  as  follows:   CAPITAL STRUCTURE  Authorised  Issued
        Mediclinic  Group  Ltd.  (Mediclinic)  (50.0%  interest),   REM  Ords no par val    1 000 000 000     529 217 007
        OUTsurance  Group  Ltd.  (OUTsurance  Group)  (30.6%   DISTRIBUTIONS [ZARc]
        interest),  Community  Investment  Ventures  Holdings   Ords no par val  Ldt  Pay  Amt
        (Pty)  Ltd.  (CIVH)  (57.0%  interest),  Heineken  Beverages   Interim No 51  21 Apr 26  28 Apr 26  173.00
        Holdings Ltd. (Heineken Beverages) (18.8% interest), RCL   Final No 50  21 Oct 25  27 Oct 25  246.70
        Foods Ltd. (RCL Foods) (79.9% interest), Rainbow (79.9%   Special  21 Oct 25  27 Oct 25  198.95
        interest),  Discovery  Ltd.  (Discovery)  (7.8%  interest),   Interim No 49  14 Apr 25  22 Apr 25  95.50
        Siqalo  Foods  (Pty)  Ltd.  (Siqalo  Foods)  (100.0%  interest),   LIQUIDITY: Jun26 Avg 6m shares p.w., R981.0m(54.4% p.a.)
        Air Products South Africa (Pty) Ltd. (Air Products) (50.0%
        interest), TotalEnergies Marketing South Africa (Pty) Ltd.   REMGRO  40 Week MA  GENF  22000
        (TotalEnergies) (24.9% interest) and Kagiso Tiso Holdings                     20000
        (Pty)  Ltd.  (KTH)  (43.5%  interest).  These  investments                    18000
        contribute approximately 88% to Remgro’s intrinsic net                        16000
        asset value (INAV after tax).
                                                                                      14000
        SECTOR: Fins--FinServcs--InvBnkng&BrokerServcs-- DiversFinServcs              12000
        MAJOR ORDINARY SHAREHOLDERS as at 30 Jun 2025                                 10000
         Public Investment Commissioner   17.31%
         Ninety One SA (Pty) Ltd.         5.10%       2022   2023   2024   2025   2026  8000
         Fairtree Asset Management (Pty) Ltd.   5.01%
        FINANCIAL STATISTICS                       RECENT ANNOUNCEMENTS
                    Dec 25  Jun 25  Jun 24  Jun 23  Jun 22
        (R million)  Interim  Final Final(rst) Final(rst) Final(rst)  Friday,  29  May  2026:  Remgro  released  a  voluntary
        Sales        27 134  51 506  50 424  48 151  41 876  statement containing a summary of Mediclinic’s financial
                                                    results  for  the  year  ended  31  March  2026.  Mediclinic
        Op Inc       2 049  3 179  2 683  2 335  2 057  Holdings Ltd. reported a strong operational performance
        NetIntPd(Rcvd)  - 259  - 341  147  17  499  for the year ended 31 March 2026, despite challenging
        Tax           695  957   948   832   757
        Minority Int  244  - 117  1 135  1 196  1 840  market  conditions.  Adjusted  revenue  increased  by
        Att Inc      5 168  3 303  1 241  9 624  13 139  11% to USD5.36 billion, driven by volume growth and
        TotCompInc/Loss  5 356  6 364  - 205  21 618  13 033  favourable mix changes. Adjusted EBITDA rose by 14%
        Hline Erngs-CO  5 175  7 827  5 646  6 642  5 816  to  USD842  million,  with  an  EBITDA  margin  of  15.7%.
        Fixed Ass    12 120  12 070  11 052  10 230  17 968  Adjusted earnings grew by 45% to USD345 million. The
        Inv in Assoc  65 216  67 132  70 038  75 792  50 771  Group’s net debt remained stable at USD2.27 billion, and
        Inv & Loans  23 401  22 449  20 066  22 747  21 047  cash  conversion  was  106%.  A  proposed  restructuring
        Def Tax Asset  284  277  194   176   219    involves Remgro acquiring full ownership of Mediclinic
        Tot Curr Ass  35 399  29 438  26 814  23 707  44 478  Southern  Africa  for  USD950  million,  and  MSC’s  IHL
        Ord SH Int  119 456 117 039  112 117  115 267  98 443  acquiring  Hirslanden  for  the  same  amount,  leading
        Minority Int  6 834  6 840  7 047  6 521  17 437  to  the  classification  of  these  divisions  as  discontinued
        LT Liab      10 342  10 419  7 030  11 787  21 128
        Tot Curr Liab  10 083  7 876  12 984  12 740  19 295  operations.  Impairment  charges  of  USD555  million
                                                    related to the Hirslanden division were recognised.
        PER SHARE STATISTICS (cents per share)
        EPS (ZARc)   930.00  591.87  222.82  1 701.02  2 315.77  Wednesday,  22  April  2026:  Remgro  has  disposed  of
        HEPS-C (ZARc)  931.00 1 401.60  1 012.65  1 173.80  1 025.58  its  remaining  39  603  406  FirstRand  shares  through
        Pct chng p.a.  32.8  38.4  - 13.7  14.5  106.0  further  on-market  transactions,  for  an  aggregate  cash
        Tr 5yr av grwth %  -  42.2  20.8  22.6  20.0  consideration of R3.59 million.
        DPS (ZARc)   173.00  541.15  262.61  238.74  149.21  Remgro  interim  results  December  2025  -  Wednesday,
        Pct chng p.a.  - 36.1  106.1  10.0  60.0  70.1  25  March  2026:  Revenue  for  the  period  went  up  to
        Tr 5yr av grwth %  -  38.0  6.8  6.0  - 4.5  R27.134 billion (2024: R26.395 billion) and trading profit
        NAV PS (ZARc)  21 481.00 20 944.38 20 097.85 20 641.98 17 360.31  increased  to  R2.049  billion  (2024:  R1.987  billion).  Net
        3 Yr Beta     0.78  0.73  0.55  0.52  0.84  profit for the period attributable to equity holders rose
        Price High   18 380  16 412  16 315  14 762  15 096  to  R5.168  billion  (2024:  R3.658  billion).  Furthermore,
        Price Low    15 681  12 860  11 539  12 143  10 458  headline earnings per share grew to 931 cents per share
        Price Prd End  18 161  15 737  13 537  14 628  12 665  (2024: 672 cents per share).
                                               166
   163   164   165   166   167   168   169   170   171   172   173